The Nasdaq indicated that there was a record amount of biotech initial public offerings (IPOs) in 2018, totaling around $8.2 billion raised, breaking 2014’s record of $6.5 billion.
Celltrion Signs ‘Incubation’ Agreement with Emory University for Development of New Drugs for Atherosclerosis
Atherosclerosis, Biologics, Biopharmaceutical, Blood Vessels, Business, Cholesterol Lowering, Contract Development Manufacturing Organization (CDMO), Incubators, Innovation, Plaque, R&D, Statins, Vascular DIseaseCelltrion Inc. signed an ‘Incubation’ agreement with Emory University in Atlanta to support the research and development of new drug candidates for atherosclerosis.
AstraZeneca has invested another $140 million in Moderna Therapeutics’ drugs based on a molecule known as messenger RNA.
(Reuters Health) – Adults who get too much or too little sleep may have the beginnings of “hardening” of the arteries, which can be an early sign of heart disease, […]
Between 1999 and 2012, the use of cholesterol-lowering statin drugs increased among people over age 79 with no history of coronary heart disease, stroke or vascular disease, according to a […]
